Bumper Offer - Urjas oil Just @ Rs. 1
Epilex 200 Tablet (15), a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Epilepsy. Epilex 200 Tablet (15) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Epilex 200 Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Epilex 200 Tablet (15) include Loss of appetite. Some other side effects of Epilex 200 Tablet (15) have been listed ahead. Such side effects of Epilex 200 Tablet (15) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Epilex 200 Tablet (15)'s effect during pregnancy is Severe and Mild while nursing. In addition, Epilex 200 Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Epilex 200 Tablet (15) related warnings section.
Epilex 200 Tablet (15) is contraindicated in people with pre-existing medical conditions like Depression, Liver Disease as it can result in adverse effects. Other contraindications of Epilex 200 Tablet (15) have been discussed in the sections ahead.
Drug interactions for Epilex 200 Tablet (15) have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Epilex 200 Tablet (15) is not safe while driving, and is is not addictive in nature.
Epilex 200 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Epilex 200 Tablet (15) is used -
Severe
Moderate
Mild
Common
Is the use of Epilex 200 Tablet (15) safe for pregnant women?
Pregnant women may get severe side effects after taking Epilex. If you are pregnant, do not take Epilex without a doctor's advice.
Is the use of Epilex 200 Tablet (15) safe during breastfeeding?
Side effects of Epilex on breastfeeding women are very mild.
What is the effect of Epilex 200 Tablet (15) on the Kidneys?
Very few cases of side effects of Epilex on kidney have been reported.
What is the effect of Epilex 200 Tablet (15) on the Liver?
Epilex has very mild side effects on the liver.
What is the effect of Epilex 200 Tablet (15) on the Heart?
You can take Epilex without any fear of damage to the heart.
Epilex 200 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Epilex 200 Tablet (15) unless your doctor advises you to do so -
Is this Epilex 200 Tablet (15) habit forming or addictive?
Forming a habit of Epilex 200 Tablet (15) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Epilex 200 Tablet (15) can make you feel drowsy.
Is it safe?
Yes, but consume Epilex 200 Tablet (15) only on doctor's advice.
Is it able to treat mental disorders?
Yes, Epilex 200 Tablet (15) is useful in treating mental disorders.
Interaction between Food and Epilex 200 Tablet (15)
It is safe to take Epilex 200 Tablet (15) with food.
Interaction between Alcohol and Epilex 200 Tablet (15)
Taking alcohol with Epilex 200 Tablet (15) can be dangerous.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
